Grand Mount Capital
Shanghai, Shanghaigmcn-capital.com
Overview
Grand Mountain (or Mount, the sources are inconsistent) is a venture capital firm jointly established by a professional investment team and state-owned assets based in Shanghai, China. The firm specializes in investing in the fields of biopharmaceuticals, medical devices, healthcare services, and diagnostics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Geneus Technologies (Chengdu) Co., Ltd. | Sep 2021 | Series B | Co-investor |
| Bioeast Biotech | Sep 2021 | Series A | Co-investor |
| Sanyou Biopharmaceuticals | Jun 2021 | Series B | Co-investor |
| HiFiBiO Therapeutics | Jun 2021 | Series D | Co-investor |
| Neurophth | Feb 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.